XML 32 R23.htm IDEA: XBRL DOCUMENT v3.25.2
Schedule of Segment Information Related to Statement of Operations (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Segment Reporting [Abstract]        
Revenue $ 129,904 $ 489,594 $ 689,680 $ 802,972
Operating Expenses:        
Employee compensation 312,560 268,776 599,072 515,686
Professional fees 44,757 50,964 132,657 114,114
Directors fees and expenses 107,107 1,065 227,107 121,306
Marketing and investor relations 48,756 47,119 79,002 97,241
Insurance [1] 45,355 46,009 91,544 98,383
Occupancy costs 20,615 14,735 42,132 30,147
Credit loss expense 124,253 124,253
Patent costs 15,313 14,454 27,117 34,196
Stock listing fees 17,500 16,375 35,000 32,750
Legal fees 1,070 3,390 1,070 27,975
Depreciation and amortization 2,864 3,718 5,723 7,422
Other operating expenses [2] 35,772 10,293 47,721 31,065
Operating expenses 775,922 476,898 1,412,398 1,110,285
Research and Development Expenses:        
Employee compensation 43,280 33,344 90,643 80,050
Insurance [1] 44,425 44,903 89,635 95,799
Occupancy costs 63,252 44,197 127,796 90,446
Depreciation and amortization 223 2,785 443 5,530
Other research and development costs 17,906 3,601 23,446 6,746
Research and development expenses 169,086 128,830 331,963 278,571
Operating loss $ (815,104) $ (116,134) $ (1,054,681) $ (585,884)
[1] Insurance includes all coverage including property, liability, directors’ and officers’ and employees’ medical.
[2] Other operating expenses and other research and development expenses consist principally of miscellaneous expenses, each of which is under the Company’s threshold to be separately presented as a significant expense.